To evaluate the impact of retinal blood flow on optic nerve head (ONH) morphology in patients with open-angle glaucoma (OAG) with and without diabetes mellitus (DM).
Methods
A total of 66 patients with OAG (14 with DM, 52 without DM) were assessed at baseline and 3-year follow-up for retinal capillary blood flow using confocal scanning laser Doppler and ocular structure using Heidelberg retinal tomography and optical coherence tomography.
Results
Change in retinal tissue with zero blood flow in the superior and inferior retina was found to have a strong correlation with ONH changes in diabetic patients (r≥0.90, p≤0.03); however, no relation was found in the nondiabetic cohort. There were also significant changes in inferior mean flow that strongly correlated with changes in cup area (r = 0.97, p = 0.0029), cup/disc area ratio (r = 0.96, p = 0.0070), linear cup/disc ratio (r = 0.93, p = 0.0172), rim area (r = −0.97, p = 0.0036), and rim volume (r = −0.95, p = 0.0084) in diabetic patients only, while changes in the superior mean flow were only significantly associated with cup area (r = −0.30, p = 0.0498), cup volume (r = −0.36, p = 0.0178), and rim volume (r = 0.35, p = 0.0193) in nondiabetic patients.
Conclusions
In this cohort of patients with OAG, changes in retinal capillary blood flow correlated more strongly with changes in ONH morphology in patients with DM than in those without DM. These data suggest that changes in retinal blood flow may play a larger role in glaucomatous ONH progression in patients with OAG with DM.
BonovasS., PeponisV., FilioussiK.Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis. Diabet Med2004; 21: 609–14.
4.
DielemansI., de JongP.T., StolkR., VingerlingJ.R., GrobbeeD.E., HofmanA.Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam Study. Ophthalmology1996; 103: 1271–5.
5.
KleinB.E., KleinR., JensenS.C.Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye Study. Ophthalmology1994; 101: 1173–7.
6.
MitchellP., SmithW., CheyT., HealeyP.R.Open-angle glaucoma and diabetes: the Blue Mountains Eye Study, Australia. Ophthalmology1997; 104: 712–8.
7.
Newman-CaseyP.A., TalwarN., NanB., MuschD.C., SteinJ.D.The relationship between components of metabolic syndrome and open-angle glaucoma. Ophthalmology2011; 118: 1318–26.
8.
de VoogdS., WolfsR.C., JansoniusN.M., WittemanJ.C., HofmanA., de JongP.T.Atherosclerosis, C-reactive protein, and risk for open-angle glaucoma: the Rotterdam Study. Invest Ophthalmol Vis Sci2006; 47: 3772–6.
9.
GordonM.O., BeiserJ.A., KassM.A.; Ocular Hypertension Treatment Study Group. Is a history of diabetes mellitus protective against developing primary open-angle glaucoma?Arch Ophthalmol2008; 126: 280–1.
TielschJ.M., KatzJ., SommerA., QuigleyH.A., JavittJ.C.Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol1995; 113: 216–21.
12.
XuL., XieX.W., WangY.X., JonasJ.B.Ocular and systemic factors associated with diabetes mellitus in the adult population in rural and urban China. The Beijing Eye Study. Eye2009; 23: 676–82.
13.
GordonM.O., BeiserJ.A., BrandtJ.D.The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol2002; 120: 714–20; discussion 829–30.
14.
FekeG.T., PasqualeL.R.Retinal blood flow response to posture change in glaucoma patients compared with healthy subjects. Ophthalmology2008; 115: 246–52.
15.
GugletaK., OrgülS., HaslerP.W., PicornellT., GherghelD., FlammerJ.Choroidal vascular reaction to hand-grip stress in subjects with vasospasm and its relevance in glaucoma. Invest Ophthalmol Vis Sci2003; 44: 1573–80.
16.
EvansD.W., HarrisA., DanisR.P., ArendO., MartinB.J.Altered retrobulbar vascular reactivity in early diabetic retinopathy. Br J Ophthalmol1997; 81: 279–82.
17.
TriggleC.R., DingH.A review of endothelial dysfunction in diabetes: a focus on the contribution of a dysfunctional eNOS. J Am Soc Hypertens2010; 4: 102–15.
18.
DimitrovaG., KatoS., YamashitaH.Relation between retrobulbar circulation and progression of diabetic retinopathy. Br J Ophthalmol2003; 87: 622–5.
19.
LudovicoJ., BernardesR., PiresI., FigueiraJ., LoboC., Cunha-VazJ.Alterations of retinal capillary blood flow in preclinical retinopathy in subjects with type 2 diabetes. Graefes Arch Clin Exp Ophthalmol2003; 241: 181–6.
20.
HarrisA., KagemannL., EhrlichR., RospigliosiC., MooreD., SieskyB.Measuring and interpreting ocular blood flow and metabolism in glaucoma. Can J Ophthalmol2008; 43: 328–36.
21.
HayrehS.S., RevieI.H., EdwardsJ.Vasogenic origin of visual field defects and optic nerve changes in glaucoma. Br J Ophthalmol1970; 54: 461–72.
22.
PrimusS., HarrisA., SieskyB.A., GuidoboniG.Diabetes: a risk factor for glaucoma?Br J Ophthalmol2011; 95: 1621–2.
23.
Abdel-GhafarR.A., MorrisT.Progress towards automated detection and characterization of the optic disc in glaucoma and diabetic retinopathy. Med Inform Internet Med2007; 32: 19–25.
24.
KawaseK., TomidokoroA., AraieM., IwaseA., YamamotoT.; Tajimi Study Group; Japan Glaucoma Society. Ocular and systemic factors related to intraocular pressure in Japanese adults: the Tajimi study. Br J Ophthalmol2008; 92: 1175–9.
25.
HeijlA., LeskeM.C., BengtssonB., HymanL., BengtssonB., HusseinM.; Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol2002; 120: 1268–79.
26.
Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol1998; 126: 498–505.
27.
CioffiG.A.Ischemic model of optic nerve injury. Trans Am Ophthalmol Soc2005; 103: 592–613.
28.
FlammerJ.[Glaucomatous optic neuropathy: a reperfusion injury.]Klin Monatsbl Augenheilkd2001; 218: 290–1.
29.
JanulevicieneI., SliesoraityteI., SieskyB., HarrisA.Diagnostic compatibility of structural and haemodynamic parameters in open-angle glaucoma patients. Acta Ophthalmol2008; 86: 552–7.
30.
Jonescu-CuypersC.P., HarrisA., WilsonR.Reproducibility of the Heidelberg retinal flowmeter in determining low perfusion areas in peripapillary retina. Br J Ophthalmol2004; 88: 1266–9.
Jonescu-CuypersC.P., HarrisA., Bartz-SchmidtK.U.Reproducibility of circadian retinal and optic nerve head blood flow measurements by Heidelberg retina flowmetry. Br J Ophthalmol2004; 88: 348–53.
33.
KagemannL., HarrisA., ChungH., Jonescu-CuypersC., ZarfatiD., MartinB.Photodetector sensitivity level and Heidelberg retina flowmeter measurements in humans. Invest Ophthalmol Vis Sci2001; 42: 354–7.
34.
MedeirosF.A., ZangwillL.M., BowdC., VessaniR.M., SusannaR.Jr., WeinrebR.N.Evaluation of retinal nerve fiber layer, optic nerve head, and macular thickness measurements for glaucoma detection using optical coherence tomography. Am J Ophthalmol2005; 139: 44–55.
35.
ZangwillL.M., van HornS., de Souza LimaM., SampleP.A., WeinrebR.N.Optic nerve head topography in ocular hypertensive eyes using confocal scanning laser ophthalmoscopy. Am J Ophthalmol1996; 122: 520–5.
36.
ShoshaniY., HarrisA., ShojaM.M.Impaired ocular blood flow regulation in patients with open-angle glaucoma and diabetes. Clin Experiment Ophthalmol2012; 40: 697–705.
ChungH.S., HarrisA., KagemannL., MartinB.Peripapillary retinal blood flow in normal tension glaucoma. Br J Ophthalmol1999; 83: 466–9.
41.
WangY., FawziA.A., VarmaR.Pilot study of optical coherence tomography measurement of retinal blood flow in retinal and optic nerve diseases. Invest Ophthalmol Vis Sci2011; 52: 840–5.
42.
ChungH.S., HarrisA., HalterP.J.Regional differences in retinal vascular reactivity. Invest Ophthalmol Vis Sci1999; 40: 2448–53.
43.
WongV.H., BuiB.V., VingrysA.J.Clinical and experimental links between diabetes and glaucoma. Clin Exp Optom2011; 94: 4–23.
44.
KimJ., DallyL.G., EdererF.AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations. Ophthalmology2004; 111: 2109–16.
45.
NagelE., VilserW., LanzlI.M.Retinal vessel reaction to short-term IOP elevation in ocular hypertensive and glaucoma patients [erratum in Eur J Ophthalmol 2002;12: 73]. Eur J Ophthalmol2001; 11: 338–44.
46.
ErdurmuşM., YağcιR., AtιşO., KaradağR., AkbaşA., HepşenI.F.Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma. Curr Eye Res2011; 36: 713–8.
47.
BagnisA., IzzottiA., CentofantiM., SaccàS.C.Aqueous humor oxidative stress proteomic levels in primary open angle glaucoma. Exp Eye Res2012; 103: 55–62.
48.
OkunoT., OkuH., SugiyamaT., GotoW., IkedaT.Evaluation of nitric oxide synthesis in the optic nerve head in vivo using microdialysis and high-performance liquid chromatography and its interaction with endothelin-1. Ophthalmic Res2003; 35: 78–83.
49.
BøtkerH.E., MøllerN.ON NO—the continuing story of nitric oxide, diabetes, and cardiovascular disease. Diabetes2013; 62: 2645–7.
50.
RajapakseN.W., ChongA.L., ZhangW.Z., KayeD.M.Insulin-mediated activation of the L-arginine nitric oxide pathway in man, and its impairment in diabetes. PLoS One2013; 8: e61840.
51.
Rodriguez-CarrizalezA.D., Castellanos-GonzalezJ.A., Martinez-RomeroE.C.Oxidants, antioxidants and mitochondrial function in non-proliferative diabetic retinopathy. J Diabetes Epub2013 Jul 22.
